NASDAQ:MRVI
Maravai LifeSciences Holdings, Inc.
- Stock
Last Close
9.21
30/08 20:00
Market Cap
1.03B
Beta: −0.23
Volume Today
1.14M
Avg: 1.43M
PE Ratio
9.61
PFCF: 8.22
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
asset turnover | 0.23 - | 0.25 7.97% | 0.22 9.75% | 0.42 86.35% | 0.39 7.14% | 0.19 49.79% | |
cash conversion cycle | 111.43 - | 82.69 25.79% | 180.71 118.54% | 166.37 7.93% | 140.97 15.27% | 168.47 19.51% | |
cash per share | 0.25 - | 0.28 12.96% | 22.82 8,118.52% | 4.80 78.95% | 4.81 0.06% | 4.36 9.30% | |
company equity multiplier | 3.74 - | 4.09 9.34% | 14.36 251.32% | 6.08 57.65% | 4.19 31.15% | 3.57 14.74% | |
days of inventory outstanding | 85.94 - | 77.54 9.77% | 152.61 96.80% | 133.88 12.27% | 93.22 30.37% | 123.96 32.97% | |
days of payables outstanding | 21.65 - | 40.83 88.61% | 37.44 8.29% | 21.17 43.45% | 12.94 38.88% | 25.88 99.93% | |
days of sales outstanding | 47.13 - | 45.98 2.46% | 65.55 42.57% | 53.67 18.13% | 60.69 13.08% | 70.39 15.99% | |
dividend yield | 0.02 - | 2.10 - | |||||
ebit per revenue | 0.13 - | 0.17 26.26% | 0.24 41.98% | 0.69 191.66% | 0.65 6.29% | -0.01 102.23% | |
ebt per ebit | -1.00 - | -0.24 75.69% | 1.21 595.32% | 0.96 20.82% | 0.96 0.36% | -147.19 15,425.54% | |
effective tax rate | -0.03 - | 0.11 540.72% | 0.04 68.35% | 0.12 228.77% | 0.11 4.86% | 1.22 1,010.04% | |
enterprise value multiple | 74.70 - | 62.28 16.63% | 6.90 88.92% | 8.82 27.71% | 3.23 63.37% | 20.19 525.16% | |
fixed asset turnover | 2.91 - | 1.52 47.81% | 2.80 84.77% | 17.25 515.12% | 7.57 56.10% | 1.30 82.86% | |
free cash flow per share | -0.04 - | 0.08 283.49% | 12.25 15,540.18% | 3.08 74.84% | 3.94 28.01% | 0.46 88.34% | |
gross profit margin | 0.51 - | 0.53 4.65% | 0.72 35.02% | 0.82 14.52% | 0.81 1.88% | 0.48 41.11% | |
interest coverage | 0.60 - | 0.80 33.48% | 2.20 174.64% | 18.33 733.53% | 28.13 53.46% | -0.09 100.33% | |
inventory turnover | 4.25 - | 4.71 10.83% | 2.39 49.19% | 2.73 13.99% | 3.92 43.61% | 2.94 24.79% | |
long term debt to capitalization | 0.70 - | 0.73 4.64% | 0.87 18.53% | 0.62 28.10% | 0.51 17.90% | 0.55 8.16% | |
net income per ebt | 1.07 - | 0.89 17.32% | 1.09 22.56% | 0.88 18.82% | 0.89 0.64% | -0.19 121.66% | |
net profit margin | -0.14 - | -0.04 74.62% | 0.31 961.90% | 0.59 87.47% | 0.56 5.36% | -0.41 174.13% | |
operating cash flow per share | -0.00 - | 0.27 13,065.05% | 14.70 5,324.13% | 3.21 78.16% | 4.07 26.90% | 0.96 76.52% | |
operating cycle | 133.08 - | 123.52 7.18% | 218.15 76.61% | 187.55 14.03% | 153.91 17.94% | 194.35 26.27% | |
operating profit margin | 0.13 - | 0.17 26.26% | 0.24 41.98% | 0.69 191.66% | 0.65 6.29% | -0.01 102.23% | |
payables turnover | 16.86 - | 8.94 46.98% | 9.75 9.04% | 17.24 76.84% | 28.20 63.60% | 14.11 49.98% | |
pretax profit margin | -0.13 - | -0.04 69.31% | 0.29 803.26% | 0.66 130.94% | 0.62 5.95% | 2.14 242.31% | |
price fair value | 18.39 - | 18.78 2.13% | 3.28 82.53% | 15.24 364.74% | 3.45 77.35% | 2.07 39.95% | |
receivables turnover | 7.74 - | 7.94 2.52% | 5.57 29.86% | 6.80 22.14% | 6.01 11.57% | 5.19 13.78% | |
return on assets | -0.03 - | -0.01 72.60% | 0.07 877.86% | 0.24 249.37% | 0.21 12.12% | -0.08 137.22% | |
return on capital employed | 0.03 - | 0.04 34.11% | 0.06 35.53% | 0.30 412.64% | 0.26 13.04% | -0.00 101.13% | |
return on equity | -0.12 - | -0.04 70.04% | 1.01 2,832.79% | 1.49 47.96% | 0.90 39.49% | -0.29 131.74% | |
total debt to capitalization | 0.70 - | 0.73 4.59% | 0.87 18.49% | 0.63 27.71% | 0.52 17.66% | 0.56 8.27% |
All numbers in USD (except ratios and percentages)